Welcome to the video course on Hematology and Oncology.
This self-study video course will help you hone your clinical and disease management skills for patients with common and chronic oncology problems and expand your competence and confidence in diagnosing and treating conditions such as Cellular Kinetics, Aplastic Anemia, Sickle Cell Disease, Thalassemias, Purpura Simplex, Hemosiderosis, Lymphocytopenia, Burkitt Lymphoma and Macroglobulinemia.
This video course will also walk you through on some Concepts, Tests and Procedures relating to the field of Hematology and Oncology.
Topics include: Coagulation Disorders, Eosinophilic Disorders, Hemostasis, Histiocytic Syndromes, Leukemias, Leukopenias, Lymphomas, Myeloproliferative Disorders, etc.
Disclaimer : The content in this course is educational in nature and intended solely as general health information. It is not a recommendation for treatment or medical advice. It is not a substitute for advice from a health care provider. If you as a patient are experiencing a medical emergency, contact your health care provider or an emergency room.
Course Curriculum
1. Overview of Cancer | |||
Overview of Cancer | 01:30:00 | ||
Cellular Kinetics | 01:30:00 | ||
Tumor Growth and Metastasis | 01:30:00 | ||
The Immune System and Cancer | 01:30:00 | ||
Cancer Diagnosis | 01:30:00 | ||
Cancer Screening | 01:30:00 | ||
Sequelae of Cancer | 01:30:00 | ||
Metastatic Carcinoma of Unknown Primary Origin | 01:30:00 | ||
General paraneoplastic symptoms | 01:30:00 | ||
Cutaneous paraneoplastic syndromes | 01:30:00 | ||
Endocrine paraneoplastic syndromes | 01:30:00 | ||
GI paraneoplastic syndromes | 01:30:00 | ||
Hematologic paraneoplastic syndromes | 01:30:00 | ||
Neurologic paraneoplastic syndromes | 01:30:00 | ||
Renal paraneoplastic syndrome | 01:30:00 | ||
Rheumatologic paraneoplastic syndromes | 01:30:00 | ||
2. Approach to the Patient With Anemia | |||
Red Blood Cell Production | 01:30:00 | ||
Etiology of Anemia | 01:30:00 | ||
Evaluation of Anemia | 01:30:00 | ||
Treatment of Anemia | 01:30:00 | ||
3. Anemias Caused by Deficient Erythropoiesis | |||
Anemia of Chronic Disease | 01:30:00 | ||
Anemia of Renal Disease | 01:30:00 | ||
Aplastic Anemia | 01:30:00 | ||
Iron Deficiency Anemia | 01:30:00 | ||
Megaloblastic Macrocytic Anemias | 01:30:00 | ||
Myelodysplasia and Iron-Transport Deficiency Anemia | 01:30:00 | ||
Myelophthisic Anemia | 01:30:00 | ||
Pure Red Blood Cell Aplasia | 01:30:00 | ||
Sideroblastic Anemias | 01:30:00 | ||
4. Anemias Caused by Hemolysis | |||
Overview of Hemolytic Anemia | 01:30:00 | ||
Autoimmune Hemolytic Anemia | 01:30:00 | ||
Embden-Meyerhof Pathway Defects | 01:30:00 | ||
Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency | 01:30:00 | ||
Hemoglobin C Disease | 01:30:00 | ||
Hemoglobin E Disease | 01:30:00 | ||
Hemoglobin S-C Disease | 01:30:00 | ||
Hemoglobin S–Beta-Thalassemia Disease | 01:30:00 | ||
Hereditary Spherocytosis and Hereditary Elliptocytosis | 01:30:00 | ||
Paroxysmal Nocturnal Hemoglobinuria (PNH) | 01:30:00 | ||
Sickle Cell Disease | 01:30:00 | ||
Stomatocytosis and Anemia Caused by Hypophosphatemia | 01:30:00 | ||
Thalassemias | 01:30:00 | ||
Traumatic Hemolytic Anemia | 01:30:00 | ||
5. Bleeding Due to Abnormal Blood Vessels | |||
Overview of Vascular Bleeding Disorders | 01:30:00 | ||
Autoerythrocyte Sensitization | 01:30:00 | ||
Dysproteinemias Causing Vascular Purpura | 01:30:00 | ||
Hereditary Hemorrhagic Telangiectasia | 01:30:00 | ||
Purpura Simplex | 01:30:00 | ||
Senile Purpura | 01:30:00 | ||
6. Coagulation Disorders | |||
Overview of Coagulation Disorders | 01:30:00 | ||
Disseminated Intravascular Coagulation (DIC) | 01:30:00 | ||
Hemophilia | 01:30:00 | ||
Coagulation Disorders Caused by Circulating Anticoagulants | 01:30:00 | ||
Uncommon Hereditary Coagulation Disorders | 01:30:00 | ||
7. Eosinophilic Disorders | |||
Eosinophil Production and Function | 01:30:00 | ||
Eosinophilia | 00:00:00 | ||
Hypereosinophilic Syndrome | 01:30:00 | ||
8. Hemostasis | |||
Overview of Hemostasis | 01:30:00 | ||
Excessive Bleeding | 01:30:00 | ||
9. Histiocytic Syndromes | |||
Overview of Histiocytic Disorders | 01:30:00 | ||
Langerhans Cell Histiocytosis | 01:30:00 | ||
Hemophagocytic Lymphohistiocytosis (HLH) | 01:30:00 | ||
Rosai-Dorfman Disease | 01:30:00 | ||
10. Iron Overload | |||
Overview of Iron Overload | 01:30:00 | ||
Hemosiderosis | 01:30:00 | ||
Hereditary Hemochromatosis | 01:30:00 | ||
Secondary Iron Overload | 01:30:00 | ||
11. Leukemias | |||
Overview of Leukemia | 01:30:00 | ||
Acute Leukemia Overview | 01:30:00 | ||
Acute Lymphocytic Leukemia (ALL) | 01:30:00 | ||
Acute Myelogenous Leukemia (AML) | 01:30:00 | ||
Chronic Lymphocytic Leukemia (CLL) | 01:30:00 | ||
Chronic Myelogenous Leukemia (CML) | 01:30:00 | ||
Myelodysplastic Syndrome | 01:30:00 | ||
12. Leukopenias | |||
Overview of Leukopenias | 01:30:00 | ||
Lymphocytopenia | 01:30:00 | ||
Monocytopenia | 01:30:00 | ||
Neutropenia | 01:30:00 | ||
13. Lymphomas | |||
Overview of Lymphoma | 01:30:00 | ||
Hodgkin Lymphoma | 01:30:00 | ||
Non-Hodgkin Lymphomas | 01:30:00 | ||
Burkitt Lymphoma | 01:30:00 | ||
Cutaneous T-cell Lymphomas (CTCL) | 01:30:00 | ||
14. Myeloproliferative Disorders | |||
Overview of Myeloproliferative Disorders | 01:30:00 | ||
Essential Thrombocythemia | 01:30:00 | ||
Reactive Thrombocytosis (Secondary Thrombocythemia) | 01:30:00 | ||
Primary Myelofibrosis | 01:30:00 | ||
Polycythemia Vera | 01:30:00 | ||
Secondary Erythrocytosis | 01:30:00 | ||
15. Plasma Cell Disorders | |||
Overview of Plasma Cell Disorders | 01:30:00 | ||
Heavy Chain Diseases | 01:30:00 | ||
Macroglobulinemia | 01:30:00 | ||
Monoclonal Gammopathy of Undetermined Significance (MGUS) | 01:30:00 | ||
Multiple Myeloma | 01:30:00 | ||
16. Principles of Cancer Therapy | |||
Overview of Cancer Therapy | 01:30:00 | ||
Surgery for Cancer | 01:30:00 | ||
Radiation Therapy for Cancer | 01:30:00 | ||
Systemic Antineoplastic Therapy | 01:30:00 | ||
Hematopoietic Cell Transplantation | 01:30:00 | ||
Management of Adverse Effects of Cancer Therapy | 01:30:00 | ||
Cachexia in Cancer | 01:30:00 | ||
Incurable Cancer | 01:30:00 | ||
17. Spleen Disorders | |||
Overview of the Spleen | 01:30:00 | ||
Splenomegaly | 01:30:00 | ||
Hypersplenism | 01:30:00 | ||
18. Thrombocytopenia and Platelet Dysfunction | |||
Overview of Platelet Disorders | 01:30:00 | ||
Acquired Platelet Dysfunction | 01:30:00 | ||
Hereditary Intrinsic Platelet Disorders | 01:30:00 | ||
Immune Thrombocytopenia (ITP) | 01:30:00 | ||
Thrombocytopenia Due to Splenic Sequestration | 01:30:00 | ||
Thrombocytopenia: Other Causes | 01:30:00 | ||
Thrombotic Thrombocytopenic Purpura (TTP) and Hemolytic-Uremic Syndrome (HUS) | 01:30:00 | ||
Von Willebrand Disease | 01:30:00 | ||
19. Thrombotic Disorders | |||
Overview of Thrombotic Disorders | 01:30:00 | ||
Antiphospholipid Antibody Syndrome (APS) | 01:30:00 | ||
Antithrombin Deficiency | 01:30:00 | ||
Hyperhomocysteinemia | 01:30:00 | ||
Factor V Resistance to Activated Protein C (APC) | 01:30:00 | ||
Protein C Deficiency | 01:30:00 | ||
Protein S Deficiency | 01:30:00 | ||
Protein Z Deficiency | 01:30:00 | ||
Prothrombin (Factor II) 20210 Gene Mutation | 01:30:00 | ||
20. Transfusion Medicine | |||
Pretransfusion Testing | 01:30:00 | ||
Blood Products | 01:30:00 | ||
Technique of Transfusion | 01:30:00 | ||
Complications of Transfusion | 01:30:00 | ||
Therapeutic Apheresis | 01:30:00 | ||
21. Tumor Immunology | |||
Tumor Antigens | 01:30:00 | ||
Host Response to Tumors | 01:30:00 | ||
Tumor Immunodiagnosis | 01:30:00 | ||
Immunotherapy of Cancer | 01:30:00 |